FibrosisIND-Stage
Myelofibrosis
Aviceda’s high-affinity ligands can selectively modulate monocyte differentiation. They regulate inflammation by inducing microenvironmental changes that can directly prevent the differentiation of monocytes to fibrocytes in myelofibrosis.
